Status:
WITHDRAWN
Impedance Cardiography to Decrease the Risk of Preeclampsia
Lead Sponsor:
University of Tennessee Medical Center
Conditions:
Chronic Hypertension Complicating Pregnancy (Diagnosis)
Preeclampsia
Eligibility:
FEMALE
18-51 years
Phase:
EARLY_PHASE1
Brief Summary
To determine if the use of impedance cardiography can identify appropriate medications for use in treating chronic hypertensive patients to decrease the risk of preeclampsia.
Detailed Description
Impedance cardiography helps determine whether vasoconstriction or an elevated cardiac output is occurring. The test is easy to perform and non invasive. The treatment for an elevated cardiac output i...
Eligibility Criteria
Inclusion
- Pregnant patients 18-51 years old Less than 20 weeks gestation with mild chronic hypertension - Not on antihypertensive medications
Exclusion
- Patients with an allergy to antihypertensive medication or contraindication for their usage such as certain cardiac or neurologic disorder during pregnancy Patients who have a blood pressure 140/90 or greater -
Key Trial Info
Start Date :
April 24 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03245970
Start Date
April 24 2017
End Date
February 29 2020
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HIgh Risk Obstetrical Consultants
Knoxville, Tennessee, United States, 37920